SI
Surgical Innovations Group plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Charmaine Day, was filed 04 Jun 2020.
Surgical Innovations Group plc: what insiders have been doing
Surgical Innovations Group plc is a listed company. Its insiders report their share dealings to RNS (LSE). Surgical Innovations Group plc has had no insider filing for more than a year; the last one goes back to 9 May 2022.
Since 2015, the database holds 22 purchases and 7 sales by insiders of the company.
Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Insider Decl.
31
Thresholds
n/a
Buy Volume
€408,903
22 ops. · all time
Sell Volume
€162,877
7 ops. · all time
Since the insiders bought
- +116.7%Entry £0.02 · Close at T+365 £0.03
- -42.0%Entry £0.03 · Close at T+365 £0.01
- -29.3%Entry £0.03 · Close at T+365 £0.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 20,433 of 26,913 companies
33.7
score / 100
Value44
Quality23
FCF yld9.2%
Earn yld-24%
EV/EBITDA·
ROE-15%
Gross mgn26%
Net mgn-7.7%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
£0.00
Analyst consensus
1 analysts£0.01Target £0.01(+250%)£0.01
Income statement
Revenue£11.6M
Gross profit£3.1M26% margin
EBITDA-£220k-2% margin
Net income-£895k-10.1% margin
Valuation
P/Book44.4x
Beta0.05
Balance sheet & cash
Market cap£3.7M
Total debt£665k
Free Cash Flow£342k
Debt / Equity17%
Profitability & ownership
ROE-14.6%
ROA-5.7%
% insiders53.6%
% institutions20.8%
Last declaration on 9 May 2022
Declarations31 total
- 449,333 shares@ £0.0222100.0% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:4363313
- 3,437,500 shares@ £0.032598.3% of flowOff-market TransactionISIN GB0004016704FCA-NSM:4040353
- 1,000,000 shares@ £0.0141100.0% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:3616624Canonical exit: 2 Sept 2020 (T+90)
- 200,000 shares@ £0.0253.5% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20191111180921_14303533_20200326185148260_21436Canonical exit: 4 Feb 2020 (T+90)
- 100,000 shares@ £0.0231.6% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20191107070013_14297982_20200326185148459_25778Canonical exit: 3 Feb 2020 (T+90)
- 500,000 shares@ £0.02247.8% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20191105145607_14295376_20200326185148562_27991Canonical exit: 30 Jan 2020 (T+90)
- 500,000 shares@ £0.02257.9% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20191025151205_14281601_20200326185153165_6895Canonical exit: 20 Jan 2020 (T+90)
- 504,644 shares@ £0.03410.4% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20190315162718_14004663_20200326185133845_14375-0
- 504,644 shares@ £0.034110.4% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20190315162718_14004663_20200326185133845_14375-1Canonical exit: 13 Jun 2019 (T+90)
- 416,830 shares@ £0.02959.0% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20181016105315_13830541_20200330111443206_14165-1
- 750,000 shares@ £0.029516.2% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20181016105315_13830541_20200330111443206_14165-0Canonical exit: 14 Jan 2019 (T+90)
- 416,830 shares@ £0.032518.5% of flowOff-marketISIN GB0004016704FCA-NSM:LSE20180911102315_13786285_20200330111447050_16191-0Canonical exit: 10 Dec 2018 (T+90)
- 416,830 shares@ £0.032523.4% of flowOff-marketISIN GB0004016704FCA-NSM:LSE20180911102315_13786285_20200330111447050_16191-1
- 967,996 shares@ £0.037540.1% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20180323152505_13579929_20200330111426972_6197-0
- 1,472,640 shares@ £0.035759.9% of flow1. & 2. - London Stock Exchange, AIM 3. - Off marketISIN GB0004016704FCA-NSM:LSE20180323152505_13579929_20200330111426972_6197-1Canonical exit: 20 Jun 2018 (T+90)
- 504,644 shares@ £0.035731.7% of flowOff marketISIN GB0004016704FCA-NSM:LSE20180323152505_13579929_20200330111426972_6197-2
- 902,584 shares@ £0.039940.3% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20180313150610_13565468_20200330111427566_18626-0Canonical exit: 11 Jun 2018 (T+90)
- 583,644 shares@ £0.039926.1% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20180313150610_13565468_20200330111427566_18626-1
- 29,690 shares@ £0.033549.7% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20171115114735_13432637_20200330131534524_12690-1Canonical exit: 8 Feb 2018 (T+90)
- 27,612 shares@ £0.03650.3% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20171115114735_13432637_20200330131534524_12690-0Canonical exit: 26 Dec 2017 (T+90)
- 305,343 shares@ £0.032858.9% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20171106070004_13420774_20200330131534126_3883Canonical exit: 1 Feb 2018 (T+90)
- 500,000 shares@ £0.03318.6% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20171031105832_13414765_20200330131538318_21316Canonical exit: 29 Jan 2018 (T+90)
- 400,000 shares@ £0.034913.4% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20170728070008_13310738_20200330131519794_19927-0Canonical exit: 25 Oct 2017 (T+90)
- 815,721 shares@ £0.034924.3% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20170728070008_13310738_20200330131519794_19927-1Canonical exit: 25 Oct 2017 (T+90)
- 401,360 shares@ £0.036100.0% of flowLondon Stock Exchange, AIMISIN GB0004016704FCA-NSM:LSE20170411090351_13190681_20200330131459158_7627Canonical exit: 9 Jul 2017 (T+90)
25 of 31 declarations
About Surgical Innovations Group plc
Surgical Innovations Group plc is a UK-based company that specializes in the design and manufacture of medical devices for surgery. It focuses on innovation in surgical technology.
